XEDITON
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

XEDITON Trademark

Serial Number: 76687381

XEDITON is a trademark filed by XEDITON PHARMACEUTICALS INC. on March 5, 2008. The trademark is classified under Class 5 (Pharmaceuticals), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

XEDITON PHARMACEUTICALS INC.

2000 Argentia Road, Building 1 Suite 260
Mississauga, Ontario L5N1P7 , CA

Entity Type: 03

Trademark Details

Filing Date

March 5, 2008

Registration Date

Not Registered

Goods & Services

Vitamins, minerals, dietary supplements; pharmaceuticals, namely, pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the digestive system, endocrine system, integumentary system, lymphatic system, muscular system, nervous system, immune system, cardiovascular system, metabolic system, reproductive system, respiratory system, skeletal system, urinary system, and eyes; pharmaceuticals, namely, pharmaceutical preparations and substances for use in gastroenterology, oncology, ophthalmology, cardiology, dermatology, haematology, chemotherapy, psychiatry, urology, and neurology; pharmaceuticals, namely, pharmaceutical preparations and substances for the prevention and treatment of blood disorders, cancer, cardiovascular diseases, carpal tunnel syndrome, dental and oral diseases, headaches, pain, varicose veins, erectile dysfunction, gout, heart rhythm disorders, infectious diseases, gastro-intestinal diseases, diabetes, skin disorders, wounds, eye diseases and disorders, bacteria based diseases, inflamation, sepsis, alopecia, obesity, cognitive disorders, bone diseases, and viruses; pharmaceuticals, namely, pharmaceutical preparations for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, and inflammatory pelvic diseases; pharmaceuticals, namely, pharmaceutical preparations for the treatment of immunologic diseases, namely, auto-immune diseases and immunologic deficiency syndrome; pharmaceuticals, namely, pharmaceutical preparations for the treatment of infectious diseases, namely, respiratory infections, and eye infections; pharmaceuticals, namely, pharmaceutical preparations for the treatment of inflammatory diseases, namely, inflammatory bowel diseases, and inflammatory connective tissue diseases; pharmaceuticals, namely, pharmaceutical preparations for the treatment of neurological diseases and disorders, namely, Alzheimer's, Huntington's Disease, cerebral palsy, brain injuries, spinal cord injuries, and seizures; pharmaceuticals, namely, pharmaceutical preparations for the treatment of psychiatric diseases and disorders, namely, mood disorders, anxiety disorders, cognitive diseases, and schizophrenia; pharmaceuticals, namely, pharmaceutical preparations for the treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular mobility disorders, and spinal cord diseases; pharmaceuticals, namely, pharmaceutical preparations for the treatment of the central nervous system, namely, encephalitis, epilepsy, Alzheimer's, cerebral palsy, and Parkinson's disease; pharmaceuticals, namely, pharmaceutical preparations for the treatment of the musculoskeletal system, namely, connective tissue disorders, bone diseases, spinal diseases, back pain, fractures, sprains, and cartilage injuries; pharmaceuticals, namely, pharmaceutical preparations for the treatment of viral diseases, namely, herpes, hepatitis, and Acquired Immune Deficiency Syndrome (AIDS); pharmaceuticals, namely, pharmaceutical preparations for the treatment of skin diseases and disorders, namely, dermatitis, skin pigmentation diseases, and sexually transmitted diseases; nutraceuticals, namely, vitamin, mineral and herbal food supplements; pharmaceuticals, namely, analgesics, muscle relaxants, antibacterial, anti-diabetics, antimicrobial preservatives, astringents, antitussive-cold preparations, anti-allergic preparations, anticoagulants antidepressants, appetite suppressants, vaccines, anti fungal preparations, antibiotics, anti-infective preparations, antiviral preparations, psychotropics, lipid lowering agents, anthelmintics, and skin lotions; nutraceuticals, namely, nutraceutical preparations and substances for the prevention and treatment of diseases and disorders of the digestive system, endocrine system, integumentary system, lymphatic system, muscular system, nervous system, immune system, cardiovascular system, metabolic system, reproductive system, respiratory system, skeletal system, urinary system, and eyes; nutraceuticals, namely, nutraceutical preparations and substances for use in gastroenterology, oncology, ophthalmology, cardiology, dermatology, haematology, chemotherapy, psychiatry, urology, and neurology; nutraceuticals, namely, nutraceutical preparations and substances for the prevention and treatment of blood disorders, cancer, cardiovascular diseases, carpal tunnel syndrome, dental and oral diseases, headaches, pain, varicose veins, erectile dysfunction, gout, heart rhythm disorders, infectious diseases, gastro-intestinal diseases, diabetes, skin disorders, wounds, eye diseases and disorders, bacteria based diseases, inflamation, sepsis, alopecia, obesity, cognitive disorders, bone diseases, and viruses; nutraceuticals, namely, nutraceutical preparations for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, and inflammatory pelvic diseases; nutraceuticals, namely, nutraceutical preparations for the treatment of immunologic diseases, namely, auto-immune diseases and immunologic deficiency syndrome; nutraceuticals, namely, nutraceutical preparations for the treatment of infectious diseases, namely, respiratory infections, and eye infections; nutraceuticals, namely, nutraceutical preparations for the treatment of inflammatory diseases, namely, inflammatory bowel diseases, and inflammatory connective tissue diseases; nutraceuticals, namely, nutraceutical preparations for the treatment of neurological diseases and disorders, namely, Alzheimer's, Huntington's Disease, cerebral palsy, brain injuries, spinal cord injuries, and seizures; nutraceuticals, namely, nutraceutical preparations for the treatment of psychiatric diseases and disorders, namely, mood disorders, anxiety disorders, cognitive diseases, and schizophrenia; nutraceuticals, namely, nutraceutical preparations for the treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular mobility disorders, and spinal cord diseases; nutraceuticals, namely, nutraceutical preparations for the treatment of the central nervous system, namely, encephalitis, epilepsy, Alzheimer's, cerebral palsy, and Parkinson's disease; nutraceuticals, namely, nutraceutical preparations for the treatment of the musculoskeletal system, namely, connective tissue disorders, bone diseases, spinal diseases, back pain, fractures, sprains, and cartilage injuries; nutraceuticals, namely, nutraceutical preparations for the treatment of viral diseases, namely, herpes, hepatitis, and Acquired Immune Deficiency Syndrome (AIDS); nutraceuticals, namely, nutraceutical preparations for the treatment of skin diseases and disorders, namely, dermatitis, skin pigmentation diseases, and sexually transmitted diseases; nutraceuticals, namely, analgesics, muscle relaxants, antibacterial, anti-diabetics, antimicrobial preservatives, astringents, antitussive-cold preparations, anti-allergic preparations, anticoagulants, antidepressants, appetite suppressants, vaccines, anti fungal preparations, antibiotics, anti-infective preparations, antiviral preparations, psychotropics, lipid lowering agents, anthelmintics, and skin lotions; chemicals for medicinal purposes, namely, calcium, hydrogen, iodine, iron, sodium, super, zinc

Providing consumer product information on pharmaceuticals, nutraceuticals, vitamins, minerals, dietary supplements, chemicals for medicinal purposes and medical devices and appliances

Filing History

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
May 21, 2012 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
May 19, 2012 ABN2
INQUIRY AS TO SUSPENSION MAILED
Oct 19, 2011 CNSI
SUSPENSION INQUIRY WRITTEN
Oct 18, 2011 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Oct 11, 2011 RCCK
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 20, 2011 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 20, 2011 COAR
LETTER OF SUSPENSION MAILED
Apr 11, 2011 CNSL
SUSPENSION LETTER WRITTEN
Apr 8, 2011 CNSL
AMENDMENT FROM APPLICANT ENTERED
Apr 4, 2011 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 4, 2011 CRFA
ASSIGNED TO LIE
Mar 18, 2011 ALIE
FAX RECEIVED
Mar 17, 2011 FAXX
INQUIRY AS TO SUSPENSION MAILED
Sep 20, 2010 CNSI
SUSPENSION INQUIRY WRITTEN
Sep 17, 2010 CNSI
LETTER OF SUSPENSION MAILED
Mar 15, 2010 CNSL
SUSPENSION LETTER WRITTEN
Mar 12, 2010 CNSL
AMENDMENT FROM APPLICANT ENTERED
Mar 10, 2010 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 10, 2010 CRFA
FAX RECEIVED
Mar 8, 2010 FAXX
INQUIRY AS TO SUSPENSION MAILED
Sep 8, 2009 CNSI
SUSPENSION INQUIRY WRITTEN
Sep 5, 2009 CNSI
LETTER OF SUSPENSION MAILED
Mar 5, 2009 CNSL
SUSPENSION LETTER WRITTEN
Mar 4, 2009 CNSL
AMENDMENT FROM APPLICANT ENTERED
Jan 7, 2009 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 7, 2009 CRFA
ASSIGNED TO LIE
Jan 7, 2009 ALIE
PAPER RECEIVED
Dec 23, 2008 MAIL
NON-FINAL ACTION MAILED
Jun 23, 2008 CNRT
NON-FINAL ACTION WRITTEN
Jun 23, 2008 CNRT
ASSIGNED TO EXAMINER
Jun 15, 2008 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 15, 2008 MAFR
NEW APPLICATION ENTERED
Mar 11, 2008 NWAP